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A 76-year-old woman presented with a 3-cm-sized tumor in the right axilla, with dermal infiltration. Core nee-
dle biopsy revealed invasive ductal carcinoma, and immunohistochemical findings revealed positivity for estro-
gen receptor (ER) and negativity for progesterone receptor (PgR) and HER2. She was diagnosed as having acces-
sory breast cancer with multiple bone metastases and was classified as stage IV. Bisphosphonate (BP) therapy
was initiated, and 78 months after starting BP therapy, she developed discomfort in her right femoral area, with
pain on walking. Plain radiographs revealed localized thickening of the right femoral lateral bone cortex. An in-
complete transverse fracture on computed tomography and low signal intensity on T1-weighted magnetic reso-
nance images in the same location suggested repair process after an atypical femoral fracture because of long-
term BP therapy. Bone scintigraphy, 1 year earlier, had shown slight right-sided lateral femoral uptake. BP ther-
apy was discontinued, and the pain improved with conservative management. At present, 30 months later, no
skeletal-related adverse events have occurred, and the atypical femoral fracture is stable. In this case, a suspicion
of atypical femoral fracture based on symptoms of advanced disease prompted the diagnosis of an incomplete
fracture. Atypical femoral fractures must be suspected in patients on long-term BP therapy.
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A Plain X-ray image. Plain X-ray images showing thickening of lateral bone cortex (arrow).
B Computed tomography. Computed tomography showing thickening of lateral bone cor-
tex (arrow).
C Magnetic resonance imaging. Magnetic resonance imaging showing thickening of lateral 
bone cortex on T1-weighted images (arrow).
Figure　2　Bone scintigraphy.
Bone scintigraphy demonstrating slight uptake in lateral 
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